Top Biotech Stocks To Buy Right Now

Broadening its focus on web-based information programs that meet the regulatory, operational, continuing education, and internal training needs of companies, Xerox (NYSE: XRX  ) announced this morning it is acquiring digital education solutions provider LearnSomething for an undisclosed sum.

The e-learning specialist focuses particularly on the�food, drug, and health care industries, and delivers programs to�85% of all U.S. retail pharmacy chains, reaching more than 110,000 retail pharmacists.

Xerox COO of Commercial Services Business�Connie Harvey said: "Xerox became one of the largest providers of�customer care services�to the pharmaceutical, biotech and health care industries when we acquired�TMS Health�in 2010.�The addition of LearnSomething broadens our capabilities tailored for these fast-growing industries and gives our clients the advantage of a progressive e-learning platform for the rapid deployment of relevant information and education tools."

Top Biotech Stocks To Buy Right Now: Nomura Holdings Inc ADR (NMR)

Nomura Holdings, Inc. provides financial services in Japan and internationally. The company operates in three divisions: Retail, Asset Management, and Wholesale. The Retail division primarily offers investment consultation services to retail clients. It also provides various financial instruments, such as stocks, debt securities, investment trusts, and variable annuity insurance products for the short, medium, and long term. As of March 31, 2011, this division operated a network of approximately 174 branches. The Asset Management division involves in the development and management of investment trusts. This division also offers investment advisory services to public and private pensions, governments and their agencies, central banks, and institutional investors. The Wholesale division engages in the fixed income and equity trading, and asset finance businesses. It provides debt securities, foreign currencies, and stocks, as well as related derivatives; and equities securit ies and equity-linked derivatives; and execution services, such as algorithmic trading and transaction cost analysis. This division also involves in underwriting various types of stocks, convertible and exchangeable securities, investment grade debt, sovereign and emerging market debt, high yield debt, structured securities, and other securities; offers financial advisory services and solutions on business transactions, including mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions; and operates private equity investment business. The company primarily serves individuals, corporations, financial institutions, governments, and governmental agencies, as well as retail and asset management clients. Nomura Holdings, Inc. was founded in 1925 and is headquartered in Tokyo, Japan.

Top Biotech Stocks To Buy Right Now: Cummins Inc.(CMI)

Cummins Inc. designs, manufactures, distributes, and services diesel and natural gas engines, electric power generation systems, and engine-related component products worldwide. It operates in four segments: Engine, Power Generation, Components, and Distribution. The Engine segment offers a range of diesel and natural gas powered engines under the Cummins and other customer brand names for the heavy-and medium-duty truck, bus, recreational vehicle, light-duty automotive, agricultural, construction, mining, marine, oil and gas, rail, and governmental equipment markets. This segment also provides new parts and service, as well as remanufactured parts and engines. The Power Generation segment offers power generation systems, components, and services, including diesel, natural gas, gasoline, and alternative-fuel electrical generator sets for use in recreational vehicles, commercial vehicles, recreational marine applications, and home stand-by or residential applications. This segment also provides components that make up power generation systems, such as engines, controls, alternators, transfer switches, and switchgears. The Components segment supplies filtration products, turbochargers, aftertreatment systems, intake and exhaust systems, and fuel systems for commercial diesel applications. This segment offers filtration and exhaust systems for on-and off-highway heavy-duty and mid-range equipment, as well as supplies filtration products for industrial and passenger car applications. This segment also develops after treatment and exhaust systems to help customers meet emissions standards and fuel systems. The Distribution segment provides parts and services, as well as service solutions, including maintenance contracts, engineering services, and integrated products. The company sells its products to original equipment manufacturers, distributors, and other customers. Cummins Inc. was founded in 1919 and is headquartered in Columbus, Indiana.

Advisors' Opinion:

• [By Matthew Scott]

  While trucking manufacturing Cummins (NYSE: CMI) is hardly a sexy stock, fleets of environmentally friendly trucks will be essential for many world economies to remain competitive as they slowly make their way out of the last recession. The price of Cummins’ stock has increased more than five and a half times in two years, jumping from $19.09 on March 9, 2009 to $109.62 at the end of the first quarter this year. As world economies begin to improve, transportation companies will begin replacing trucks so that they can move higher volumes of products more efficiently, and Cummins will benefit.

10 Best Heal Care Stocks To Invest In Right Now: Poniard Pharmaceuticals Inc.(PARD)

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.